Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Volpert

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Molecular Pharmacology|February 3, 1999
Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeatD W Dawson, O V Volpert, S F Pearce, et al.
The Journal of Urology|April 25, 2008
Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanismNorm D Smith, Frank Thilo Schulze-Hoepfner, Dorina Veliceasa, et al.
Cancer Research|December 15, 1996
Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1S C Hsu, O V Volpert, P A Steck, et al.
The Journal of Experimental Medicine|March 10, 2001
Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2G L Hernández, O V Volpert, M A Iñiguez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2004
Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vesselsSusan E Crawford, Constantine Mavroudis, Carl L Backer, et al.
Oncotarget|December 20, 2014
Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1Xin Tong, Salida Mirzoeva, Dorina Veliceasa, et al.
International Journal of Cancer|May 10, 2007
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivoThomas Nelius, Stephanie Filleur, Alexander Yemelyanov, et al.
Molecular Cancer Research : MCR|October 23, 2004
Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510Hanhua Huang, Steven C Campbell, Dhugal F Bedford, et al.
Blood|March 6, 2010
NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacementArin B Aurora, Aryn B Aurora, Dauren Biyashev, et al.
International Journal of Cancer|March 29, 2002
Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimeticsFrank K Reiher, Olga V Volpert, Benilde Jimenez, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Molecular Pharmacology|February 3, 1999
Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeatD W Dawson, O V Volpert, S F Pearce, et al.
The Journal of Urology|April 25, 2008
Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanismNorm D Smith, Frank Thilo Schulze-Hoepfner, Dorina Veliceasa, et al.
Cancer Research|December 15, 1996
Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1S C Hsu, O V Volpert, P A Steck, et al.
The Journal of Experimental Medicine|March 10, 2001
Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2G L Hernández, O V Volpert, M A Iñiguez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2004
Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vesselsSusan E Crawford, Constantine Mavroudis, Carl L Backer, et al.
Oncotarget|December 20, 2014
Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1Xin Tong, Salida Mirzoeva, Dorina Veliceasa, et al.
International Journal of Cancer|May 10, 2007
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivoThomas Nelius, Stephanie Filleur, Alexander Yemelyanov, et al.
Molecular Cancer Research : MCR|October 23, 2004
Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510Hanhua Huang, Steven C Campbell, Dhugal F Bedford, et al.
Blood|March 6, 2010
NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacementArin B Aurora, Aryn B Aurora, Dauren Biyashev, et al.
International Journal of Cancer|March 29, 2002
Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimeticsFrank K Reiher, Olga V Volpert, Benilde Jimenez, et al.
Pageof 12